Predictors of autosomal dominant polycystic kidney disease progression
- PMID: 24925719
- PMCID: PMC4214531
- DOI: 10.1681/ASN.2013111184
Predictors of autosomal dominant polycystic kidney disease progression
Abstract
Autosomal dominant polycystic kidney disease is a genetic disorder associated with substantial variability in its natural course within and between affected families. Understanding predictors for rapid progression of this disease has become increasingly important with the emergence of potential new treatments. This systematic review of the literature since 1988 evaluates factors that may predict and/or effect autosomal dominant polycystic kidney disease progression. Predicting factors associated with early adverse structural and/or functional outcomes are considered. These factors include PKD1 mutation (particularly truncating mutation), men, early onset of hypertension, early and frequent gross hematuria, and among women, three or more pregnancies. Increases in total kidney volume and decreases in GFR and renal blood flow greater than expected for a given age also signify rapid disease progression. Concerning laboratory markers include overt proteinuria, macroalbuminuria, and perhaps, elevated serum copeptin levels in affected adults. These factors and others may help to identify patients with autosomal dominant polycystic kidney disease who are most likely to benefit from early intervention with novel treatments.
Keywords: PKD1/PKD2; autosomal dominant polycystic kidney disease; disease progression; hypertension; renal blood flow; total kidney volume.
Copyright © 2014 by the American Society of Nephrology.
Figures
References
-
- Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 - PubMed
-
- Fick-Brosnahan GM, Ecder T, Schrier RW: Polycystic kidney disease. In: Diseases of the Kidney, 7th Ed., edited by Schrier R, Philadelphia, Lippincott Williams & Wilkins, 2001, pp 547–588
-
- Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Jr., Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP, CRISP Investigators : Volume progression in polycystic kidney disease. N Engl J Med 354: 2122–2130, 2006 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous